Top compounds associated with response to STRN4


Feature Type Standardized
Nominal ANOVA
mRNA Cytarabine CTRPv2 pan-cancer AAC 0.093 0.001
mRNA BRD-K27188169:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.17 0.001
mRNA lapatinib CCLE pan-cancer AAC 0.14 0.001
mRNA Bax channel blocker CTRPv2 pan-cancer AAC 0.12 0.002
mRNA indisulam CTRPv2 pan-cancer AAC 0.1 0.002
mRNA Methotrexate GDSC1000 pan-cancer AAC 0.091 0.002
mRNA ceranib-2 CTRPv2 pan-cancer AAC 0.1 0.002
mRNA LY-2183240 CTRPv2 pan-cancer AAC 0.1 0.002
mRNA BRD-K78574327 CTRPv2 pan-cancer AAC 0.23 0.002
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.002
Download CSV